Volitionrx (VNRX) Depreciation & Amortization (CF) (2019 - 2025)
Volitionrx filings provide 9 years of Depreciation & Amortization (CF) readings, the most recent being $230824.0 for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) fell 21.92% to $230824.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $983706.0, a 11.63% decrease, with the full-year FY2025 number at $983706.0, down 11.63% from a year prior.
- Depreciation & Amortization (CF) hit $230824.0 in Q4 2025 for Volitionrx, down from $248253.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $296587.0 in Q4 2023 to a low of $224310.0 in Q1 2022.
- Median Depreciation & Amortization (CF) over the past 5 years was $250454.5 (2022), compared with a mean of $256543.8.
- Biggest five-year swings in Depreciation & Amortization (CF): surged 42.7% in 2021 and later fell 21.92% in 2025.
- Volitionrx's Depreciation & Amortization (CF) stood at $236847.0 in 2021, then increased by 5.12% to $248968.0 in 2022, then rose by 19.13% to $296587.0 in 2023, then dropped by 0.32% to $295642.0 in 2024, then fell by 21.92% to $230824.0 in 2025.
- The last three reported values for Depreciation & Amortization (CF) were $230824.0 (Q4 2025), $248253.0 (Q3 2025), and $252688.0 (Q2 2025) per Business Quant data.